Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular and microbial membranes are fundamental biological barriers composed primarily of phospholipid bilayers interspersed with proteins and sterols. They serve as the primary interface between a cell and its environment, regulating the transport of ions, nutrients, and waste products while maintaining electrochemical gradients essential for life (Alberts et al., Molecular Biology of the Cell, 2002). In pharmacology, these membranes are critical targets for antimicrobial and antifungal agents that exploit structural differences between host and pathogen (PMID: 27337121). For instance, polymyxins target the outer membrane of Gram-negative bacteria by binding to lipopolysaccharides, while polyene antifungals like amphotericin B bind to ergosterol in fungal membranes to create lethal pores (PubChem CID 5280965). Daptomycin represents another class that targets the cytoplasmic membrane of Gram-positive bacteria, causing rapid depolarization (StatPearls NBK534110). Because of the structural similarities between microbial and mammalian membranes, drugs targeting these structures often face challenges regarding therapeutic index. Systemic toxicities, such as nephrotoxicity and neurotoxicity, are common safety concerns when these agents interact non-specifically with human cellular membranes (PMID: 27337121). Despite these challenges, membrane-targeting drugs remain essential "last-resort" treatments for multi-drug resistant infections.
Membrane disruption, pore formation, lipid sequestration, and depolarization of the membrane potential.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular and microbial membranes.